• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存在多种混杂因素时,疾病风险评分、倾向评分和传统多变量结局回归的表现。

Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.

机构信息

Department of Biostatistics, S-2323 Medical Center North, Vanderbilt University,Nashville, TN 37232-2158, USA.

出版信息

Am J Epidemiol. 2011 Sep 1;174(5):613-20. doi: 10.1093/aje/kwr143. Epub 2011 Jul 12.

DOI:10.1093/aje/kwr143
PMID:21749976
Abstract

Propensity scores are widely used in cohort studies to improve performance of regression models when considering large numbers of covariates. Another type of summary score, the disease risk score (DRS), which estimates disease probability conditional on nonexposure, has also been suggested. However, little is known about how it compares with propensity scores. Monte Carlo simulations were conducted comparing regression models using the DRS and the propensity score with models that directly adjust for all of the individual covariates. The DRS was calculated in 2 ways: from the unexposed population and from the full cohort. Compared with traditional multivariable outcome regression models, all 3 summary scores had comparable performance for moderate correlation between exposure and covariates and, for strong correlation, the full-cohort DRS and propensity score had comparable performance. When traditional methods had model misspecification, propensity scores and the full-cohort DRS had superior performance. All 4 models were affected by the number of events per covariate, with propensity scores and traditional multivariable outcome regression least affected. These data suggest that, for cohort studies for which covariates are not highly correlated with exposure, the DRS, particularly that calculated from the full cohort, is a useful tool.

摘要

倾向评分在考虑大量协变量的队列研究中被广泛用于提高回归模型的性能。另一种汇总评分,即疾病风险评分(DRS),它估计了在无暴露条件下的疾病概率,也已被提出。然而,对于它与倾向评分的比较,我们知之甚少。通过比较直接调整所有个体协变量的使用 DRS 和倾向评分的回归模型与使用模型,进行了蒙特卡罗模拟。DRS 以两种方式计算:从不暴露人群和整个队列。与传统的多变量结局回归模型相比,所有 3 种汇总评分在暴露与协变量之间存在中度相关性时表现相当,而在强相关性时,全队列 DRS 和倾向评分的表现相当。当传统方法存在模型误定时,倾向评分和全队列 DRS 的表现更好。所有 4 种模型都受到每个协变量的事件数的影响,倾向评分和传统的多变量结局回归受影响最小。这些数据表明,对于协变量与暴露没有高度相关的队列研究,DRS,特别是从整个队列计算的 DRS,是一种有用的工具。

相似文献

1
Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.存在多种混杂因素时,疾病风险评分、倾向评分和传统多变量结局回归的表现。
Am J Epidemiol. 2011 Sep 1;174(5):613-20. doi: 10.1093/aje/kwr143. Epub 2011 Jul 12.
2
Are propensity scores really superior to standard multivariable analysis?倾向评分是否真的优于标准多变量分析?
Contemp Clin Trials. 2011 Sep;32(5):731-40. doi: 10.1016/j.cct.2011.05.006. Epub 2011 May 16.
3
Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder.评估倾向得分模型的拟合优度检验的弱点:遗漏混杂因素的情况。
Pharmacoepidemiol Drug Saf. 2005 Apr;14(4):227-38. doi: 10.1002/pds.986.
4
Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score.在使用倾向得分进行协变量调整来估计治疗效果时,倾向得分模型的拟合优度诊断。
Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1202-17. doi: 10.1002/pds.1673.
5
Adjusting for Confounding in Early Postlaunch Settings: Going Beyond Logistic Regression Models.调整上市后早期阶段的混杂因素:超越逻辑回归模型
Epidemiology. 2016 Jan;27(1):133-42. doi: 10.1097/EDE.0000000000000388.
6
Bayesian propensity score analysis for observational data.针对观察性数据的贝叶斯倾向得分分析。
Stat Med. 2009 Jan 15;28(1):94-112. doi: 10.1002/sim.3460.
7
Adjustment for multiple cardiovascular risk factors using a summary risk score.使用综合风险评分对多种心血管危险因素进行调整。
Epidemiology. 2008 Jan;19(1):30-7. doi: 10.1097/EDE.0b013e31815be000.
8
Advanced statistics: the propensity score--a method for estimating treatment effect in observational research.高级统计学:倾向得分——一种在观察性研究中估计治疗效果的方法。
Acad Emerg Med. 2004 Sep;11(9):953-61. doi: 10.1197/j.aem.2004.02.530.
9
Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments.具有众多协变量和较少结局的研究:选择协变量并实施基于倾向评分的混杂调整。
Epidemiology. 2014 Mar;25(2):268-78. doi: 10.1097/EDE.0000000000000069.
10
Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods.使用多变量Cox比例风险回归和倾向评分方法进行调整后比较治疗效果。
Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):1-8. doi: 10.1002/pds.1520.

引用本文的文献

1
Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab.美国启动罗莫佐单抗治疗的医疗保险参保者在新冠疫情封锁期间的社会经济脆弱性与骨质疏松症治疗差异
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07677-w.
2
High-Dimensional Disease Risk Score for Dealing With Residual Confounding Bias in Estimating Treatment Effects With a Survival Outcome.用于处理生存结局估计治疗效果时残余混杂偏倚的高维疾病风险评分
Pharmacoepidemiol Drug Saf. 2025 Jul;34(7):e70172. doi: 10.1002/pds.70172.
3
Use of Machine Learning to Compare Disease Risk Scores and Propensity Scores Across Complex Confounding Scenarios: A Simulation Study.
利用机器学习比较复杂混杂情况下的疾病风险评分和倾向评分:一项模拟研究。
Pharmacoepidemiol Drug Saf. 2025 Jun;34(6):e70165. doi: 10.1002/pds.70165.
4
Hospitalized Cancer Patients with Opioid Management for Chemo-Induced Ulcerative Mucositis Lessens the Patients' Overall Burden of Illness.接受阿片类药物治疗化疗引起的溃疡性粘膜炎的住院癌症患者减轻了患者的总体疾病负担。
Pharmaceuticals (Basel). 2025 Apr 6;18(4):536. doi: 10.3390/ph18040536.
5
Major Adverse Cardiovascular Events After Colorectal Cancer Surgery, Oncological Outcomes, and Long-term Mortality: A Nationwide Retrospective Propensity Score-Matched Cohort Study.结直肠癌手术后的主要不良心血管事件、肿瘤学结局和长期死亡率:一项全国性回顾性倾向评分匹配队列研究
Ann Surg Open. 2025 Mar 6;6(1):e560. doi: 10.1097/AS9.0000000000000560. eCollection 2025 Mar.
6
Characterizing Treatment Effect Heterogeneity Using Real-World Data.使用真实世界数据表征治疗效果异质性
Clin Pharmacol Ther. 2025 May;117(5):1209-1216. doi: 10.1002/cpt.3627. Epub 2025 Mar 6.
7
Methods to Adjust for Confounding in Test-Negative Design COVID-19 Effectiveness Studies: Simulation Study.检测阴性设计的 COVID-19 有效性研究中调整混杂因素的方法:模拟研究
JMIR Form Res. 2025 Jan 27;9:e58981. doi: 10.2196/58981.
8
Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis.高维数据中倾向和疾病风险评分估计的机器学习方法:模式模拟与真实世界数据队列分析
Front Pharmacol. 2024 Oct 28;15:1395707. doi: 10.3389/fphar.2024.1395707. eCollection 2024.
9
Association of Drug-Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis.住院中老年患者药物-疾病相互作用与死亡率或再入院率的关联:一项系统评价和荟萃分析
Drugs Real World Outcomes. 2024 Sep;11(3):345-360. doi: 10.1007/s40801-024-00432-3. Epub 2024 Jun 9.
10
HbA1c changes in a deprived population who followed or not a diabetes self-management programme, organised in a multi-professional primary care practice: a historical cohort study on 207 patients between 2017 and 2019.HbA1c 变化在一个贫困人群中,他们是否遵循糖尿病自我管理计划,在一个多专业的初级保健实践中组织:一项在 2017 年至 2019 年间对 207 名患者进行的历史队列研究。
BMC Endocr Disord. 2024 May 20;24(1):72. doi: 10.1186/s12902-024-01601-9.